Functionally, the basal ganglia consists of the striatum, the pallidum and the substantia nigra. These nuclei are a target for drugs used in the treatment of number of neuropsychiatric disorders, and are implicated in chronic neuronal dysfunctions such as Parkinson's disease, Huntington's chorea and tardive dyskinesia. GABA, an inhibitory neurotransmitter synthesized by glutamic acid decarboxylase (GAD) is the major neurotransmitter in these nuclei. We have shown that levels of GAD and GAD mRNA are modified in neurons of the basal ganglia after lesions of cortical and dopaminergic afferents, and chronic administration of antipsychotics. These observations suggest that GAD gene expression is regulated in GABA- ergic neurons in response to alteration of their activity and reveal novel information on the long term effects of lesions and pharmacological treatments on discrete populations of basal ganglia neurons. The research proposed in this application will extend this analysis to the role of other key neurotransmitter systems of the basal ganglia in regulating GAD gene expression in these brain regions. Three major sets of neurons will be examined: the subthalamic nucleus, the serotonergic projection from midbrain raphes, and intrastriatal cholinergic neurons. An additional goal will be to compare the regulation of genes encoding two distinct isoforms of GAD (Molecular weight 65,000 and 67,000 daltons) and of the corresponding immunoreactive proteins. For mRNAs, the main method of approach will be in situ hybridization histochemistry and quantitative autoradiography at the single-cell level in topographically identified neurons. The levels of GAD mRNA will be compared to those of each GAD isoform by quantitative immunohistochemistry with monospecific antibodies. Results will be compared with changes in the level of enkephalin and substance P mRNAs, neuropeptides co-localized with GABA in distinct subsets of striatal efferent neurons. The results of these experiments will provide new insights into the molecular regulation of GABA-ergic neurotransmission in the brain. In addition, by providing unique information on the effect of drugs used in the treatment of psychiatric illness on subpopulations of GABA-ergic neurons in the basal ganglia, the results will help to identify new directions in the treatment of psychiatric symptoms in diseases of the basal ganglia, and help in the development of antipsychotic drugs with less extrapyramidal side effects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37MH044894-05
Application #
3486945
Study Section
Special Emphasis Panel (SRCM)
Project Start
1990-02-01
Project End
1997-01-31
Budget Start
1993-02-01
Budget End
1994-01-31
Support Year
5
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Navailles, Sylvia; Lagière, Mélanie; Roumegous, Audrey et al. (2013) Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease. Int J Neuropsychopharmacol 16:593-606
Lagière, M; Navailles, S; Mignon, L et al. (2013) The enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates. Exp Brain Res 230:513-24
De Deurwaerdere, Philippe; Le Moine, Catherine; Chesselet, Marie-Francoise (2010) Selective blockade of serotonin 2C receptor enhances Fos expression specifically in the striatum and the subthalamic nucleus within the basal ganglia. Neurosci Lett 469:251-5
Cummings, Damian M; Yamazaki, Irene; Cepeda, Carlos et al. (2008) Neuronal coupling via connexin36 contributes to spontaneous synaptic currents of striatal medium-sized spiny neurons. J Neurosci Res 86:2147-58
Wu, Nanping; Cepeda, Carlos; Zhuang, Xiaoxi et al. (2007) Altered corticostriatal neurotransmission and modulation in dopamine transporter knock-down mice. J Neurophysiol 98:423-32
Chesselet, Marie-Francoise; Plotkin, Joshua L; Wu, Nanping et al. (2007) Development of striatal fast-spiking GABAergic interneurons. Prog Brain Res 160:261-72
Plotkin, Joshua L; Wu, Nanping; Chesselet, Marie-Francoise et al. (2005) Functional and molecular development of striatal fast-spiking GABAergic interneurons and their cortical inputs. Eur J Neurosci 22:1097-108
Mehta, A; Eberle-Wang, K; Chesselet, M F (2001) Increased m-CPP-induced oral dyskinesia after lesion of serotonergic neurons. Pharmacol Biochem Behav 68:347-53
Mehta, A; Bot, G; Reisine, T et al. (2001) Endomorphin-1: induction of motor behavior and lack of receptor desensitization. J Neurosci 21:4436-42
Menalled, L; Zanjani, H; MacKenzie, L et al. (2000) Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease. Exp Neurol 162:328-42

Showing the most recent 10 out of 40 publications